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ABSTRACT 
Background: Basal cell carcinoma (BCC) develops predominantly in sun-exposed skin in 
fair-skinned individuals prone to sunburn. BCC typically occurs in adults. High exposure to 
ultraviolet (UV) radiation increases rate of developing BCC, a slowly growing tumor that 
occurs in hair-growing squamous epithelium and rarely metastasizes. In genetic studies, BCC 
patients have cell-cycle abnormalities of different parts of the signaling pathway. 
Retinoblastoma regulatory pathway is important in cell cycle arrest. In this pathway, 
p16INK4a, an inhibitor of Rb pathway, binds to CDK4 and CDK6 competitively with cyclin 
D1 to prevent phosphorylation of tumor suppressor pRB gene. Alteration of this pathway 
contributes to development of human cancers and also is effective in skin cancers. In this 
study, we analyzed mRNA expression using in situ RT-PCR and the role of 
immunohistochemical expression of p16INK4a in BCC. Methods: Expression of p16 in ten 
samples of Iranian paraffin-embedded skin BCC were studied using in situ RT-PCR and 
immunohistochemistry on p16INK4a gene. Results: Nuclear and cytoplasmic staining 
intensity of samples within tumor cells and normal skin tissue illustrates different mRNA and 
protein expression of p16 gene. mRNA of p16 gene and the expressed protein induce cell 
cycle proliferation and involve both tumor tissue as well as normal skin tissue. However, in 
this study it was found that there is significant protein and mRNA expression in BCC cells 
when compared to normal skin tissue (p <0.05). Conclusions: p16 gene is involved in the 
pathogenesis of human skin BCC in view of increased p16 mRNA and expressed protein 
within tumor cells. 
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